{
    "Variants Include": [
        {
            "Gene": "PINK1",
            "variants": [
                {
                    "HGVS": "NM_032409.3:c.926G>A",
                    "cDNA Change": {
                        "transcript": "NM_032409.3",
                        "ref": "G",
                        "alt": "A",
                        "position": "926"
                    },
                    "Protein Change": {
                        "ref": "G",
                        "alt": "D",
                        "position": "309"
                    },
                    "Description in input context": "G309D"
                },
                {
                    "HGVS": "NM_032409.3:c.1040T>C",
                    "cDNA Change": {
                        "transcript": "NM_032409.3",
                        "ref": "T",
                        "alt": "C",
                        "position": "1040"
                    },
                    "Protein Change": {
                        "ref": "L",
                        "alt": "P",
                        "position": "347"
                    },
                    "Description in input context": "L347P"
                }
            ]
        },
        {
            "Gene": "parkin",
            "variants": [
                {
                    "HGVS": "NM_004562.3:c.720A>C",
                    "cDNA Change": {
                        "transcript": "NM_004562.3",
                        "ref": "A",
                        "alt": "C",
                        "position": "720"
                    },
                    "Protein Change": {
                        "ref": "T",
                        "alt": "R",
                        "position": "240"
                    },
                    "Description in input context": "T240R"
                },
                {
                    "HGVS": "NM_004562.3:c.933C>T",
                    "cDNA Change": {
                        "transcript": "NM_004562.3",
                        "ref": "C",
                        "alt": "T",
                        "position": "933"
                    },
                    "Protein Change": {
                        "ref": "Q",
                        "alt": "X",
                        "position": "311"
                    },
                    "Description in input context": "Q311X"
                },
                {
                    "HGVS": "NM_004562.3:c.1244C>A",
                    "cDNA Change": {
                        "transcript": "NM_004562.3",
                        "ref": "C",
                        "alt": "A",
                        "position": "1244"
                    },
                    "Protein Change": {
                        "ref": "T",
                        "alt": "N",
                        "position": "415"
                    },
                    "Description in input context": "T415N"
                }
            ]
        }
    ],
    "Described Disease": {
        "Described Disease": "Parkinson Disease",
        "MONDO": "MONDO:0005180"
    },
    "Experiment Method": [
        {
            "Assay Method": "Co-Immunoprecipitation",
            "Material used": {
                "Material Source": "Cell line",
                "Material Name": "SH-SY5Y",
                "Description": "Human SH-SY5Y cells were cultured and transfected with plasmids for co-immunoprecipitation analysis."
            },
            "Readout type": "Qualitative",
            "Readout description": [
                {
                    "Variant": "NM_032409.3:c.926G>A",
                    "Conclusion": "Normal",
                    "Molecular Effect": "No Effect",
                    "Result Description": "The interaction of PINK1 G309D with parkin was not affected by the mutation."
                },
                {
                    "Variant": "NM_032409.3:c.1040T>C",
                    "Conclusion": "Normal",
                    "Molecular Effect": "No Effect",
                    "Result Description": "The interaction of PINK1 L347P with parkin was not affected by the mutation."
                },
                {
                    "Variant": "NM_004562.3:c.720A>C",
                    "Conclusion": "Abnormal",
                    "Molecular Effect": "partial loss-of-function",
                    "Result Description": "Parkin T240R mutation significantly reduced the interaction with PINK1."
                },
                {
                    "Variant": "NM_004562.3:c.933C>T",
                    "Conclusion": "Normal",
                    "Molecular Effect": "No Effect",
                    "Result Description": "Parkin Q311X mutation did not affect the interaction with PINK1."
                },
                {
                    "Variant": "NM_004562.3:c.1244C>A",
                    "Conclusion": "Normal",
                    "Molecular Effect": "No Effect",
                    "Result Description": "Parkin T415N mutation had no effect on the interaction with PINK1."
                }
            ],
            "Biological replicates": {
                "Biological replicates": "N.D.",
                "Description": "Not described in the literature."
            },
            "Technical replicates": {
                "Technical replicates": "N.D.",
                "Description": "Not described in the literature."
            },
            "Basic positive control": {
                "Basic positive control": "N.D.",
                "Description": "Not described in the literature."
            },
            "Basic negative control": {
                "Basic negative control": "Yes",
                "Description": "Pre-immune serum was used as a negative control for endogenous interaction studies."
            },
            "Validation controls P/LP": {
                "Validation controls P/LP": "N.D.",
                "Counts": "0"
            },
            "Validation controls B/LB": {
                "Validation controls B/LB": "N.D.",
                "Counts": "0"
            },
            "Statistical analysis method": {
                "Statistical analysis method": "Not described in the literature for this assay."
            },
            "Threshold for normal readout": {
                "Threshold for normal readout": "Presence of co-immunoprecipitated bands on immunoblot.",
                "Source": "Custom"
            },
            "Threshold for abnormal readout": {
                "Threshold for abnormal readout": "Absence or significant reduction of co-immunoprecipitated bands on immunoblot.",
                "Source": "Custom"
            },
            "Approved assay": {
                "Approved assay": "Yes"
            }
        },
        {
            "Assay Method": "In Vitro Phosphorylation Assay",
            "Material used": {
                "Material Source": "Recombinant Protein",
                "Material Name": "Purified PINK1 and parkin",
                "Description": "Affinity-purified FLAG-tagged PINK1 and Myc-tagged parkin were used for in vitro phosphorylation assays."
            },
            "Readout type": "Qualitative",
            "Readout description": [
                {
                    "Variant": "NM_032409.3:c.926G>A",
                    "Conclusion": "Abnormal",
                    "Molecular Effect": "complete loss-of-function",
                    "Result Description": "PINK1 G309D mutation abrogated the phosphorylation of parkin in vitro."
                },
                {
                    "Variant": "NM_032409.3:c.1040T>C",
                    "Conclusion": "Abnormal",
                    "Molecular Effect": "complete loss-of-function",
                    "Result Description": "PINK1 L347P mutation abrogated the phosphorylation of parkin in vitro."
                },
                {
                    "Variant": "NM_004562.3:c.720A>C",
                    "Conclusion": "N.D.",
                    "Molecular Effect": "N.D.",
                    "Result Description": "Not specifically tested for phosphorylation effects in this assay."
                },
                {
                    "Variant": "NM_004562.3:c.933C>T",
                    "Conclusion": "N.D.",
                    "Molecular Effect": "N.D.",
                    "Result Description": "Not specifically tested for phosphorylation effects in this assay."
                },
                {
                    "Variant": "NM_004562.3:c.1244C>A",
                    "Conclusion": "N.D.",
                    "Molecular Effect": "N.D.",
                    "Result Description": "Not specifically tested for phosphorylation effects in this assay."
                }
            ],
            "Biological replicates": {
                "Biological replicates": "N.D.",
                "Description": "Not described in the literature."
            },
            "Technical replicates": {
                "Technical replicates": "N.D.",
                "Description": "Not described in the literature."
            },
            "Basic positive control": {
                "Basic positive control": "Yes",
                "Description": "Wild-type PINK1 was used as a positive control for phosphorylation activity."
            },
            "Basic negative control": {
                "Basic negative control": "Yes",
                "Description": "Kinase-dead PINK1 KDD mutation was used as a negative control."
            },
            "Validation controls P/LP": {
                "Validation controls P/LP": "N.D.",
                "Counts": "0"
            },
            "Validation controls B/LB": {
                "Validation controls B/LB": "N.D.",
                "Counts": "0"
            },
            "Statistical analysis method": {
                "Statistical analysis method": "Not described in the literature for this assay."
            },
            "Threshold for normal readout": {
                "Threshold for normal readout": "Detection of phosphorylation signal by anti-phosphoserine antibody.",
                "Source": "Custom"
            },
            "Threshold for abnormal readout": {
                "Threshold for abnormal readout": "Absence of phosphorylation signal by anti-phosphoserine antibody.",
                "Source": "Custom"
            },
            "Approved assay": {
                "Approved assay": "Yes"
            }
        },
        {
            "Assay Method": "In Vivo Phosphorylation Assay",
            "Material used": {
                "Material Source": "Cell line",
                "Material Name": "SH-SY5Y",
                "Description": "SH-SY5Y cells were transfected with plasmids to assess in vivo phosphorylation of parkin by PINK1."
            },
            "Readout type": "Quantitative",
            "Readout description": [
                {
                    "Variant": "NM_032409.3:c.926G>A",
                    "Conclusion": "Abnormal",
                    "Molecular Effect": "complete loss-of-function",
                    "Result Description": "PINK1 G309D mutation abolished the ability to promote in vivo parkin phosphorylation."
                },
                {
                    "Variant": "NM_032409.3:c.1040T>C",
                    "Conclusion": "Abnormal",
                    "Molecular Effect": "complete loss-of-function",
                    "Result Description": "PINK1 L347P mutation abolished the ability to promote in vivo parkin phosphorylation."
                },
                {
                    "Variant": "NM_004562.3:c.720A>C",
                    "Conclusion": "N.D.",
                    "Molecular Effect": "N.D.",
                    "Result Description": "Not specifically tested for phosphorylation effects in this assay."
                },
                {
                    "Variant": "NM_004562.3:c.933C>T",
                    "Conclusion": "N.D.",
                    "Molecular Effect": "N.D.",
                    "Result Description": "Not specifically tested for phosphorylation effects in this assay."
                },
                {
                    "Variant": "NM_004562.3:c.1244C>A",
                    "Conclusion": "N.D.",
                    "Molecular Effect": "N.D.",
                    "Result Description": "Not specifically tested for phosphorylation effects in this assay."
                }
            ],
            "Biological replicates": {
                "Biological replicates": "Yes",
                "Description": "Experiments were performed in triplicate and repeated at least three times."
            },
            "Technical replicates": {
                "Technical replicates": "N.D.",
                "Description": "Not described in the literature."
            },
            "Basic positive control": {
                "Basic positive control": "Yes",
                "Description": "Wild-type PINK1 overexpression was used as a positive control."
            },
            "Basic negative control": {
                "Basic negative control": "Yes",
                "Description": "Vector-transfected control cells were used as a negative control."
            },
            "Validation controls P/LP": {
                "Validation controls P/LP": "N.D.",
                "Counts": "0"
            },
            "Validation controls B/LB": {
                "Validation controls B/LB": "N.D.",
                "Counts": "0"
            },
            "Statistical analysis method": {
                "Statistical analysis method": "ANOVA was used for statistical analysis with a P-value of less than 0.05 considered significant."
            },
            "Threshold for normal readout": {
                "Threshold for normal readout": "Significant increase in phosphorylation signal compared to vector control.",
                "Source": "Literature"
            },
            "Threshold for abnormal readout": {
                "Threshold for abnormal readout": "No significant increase in phosphorylation signal compared to vector control.",
                "Source": "Literature"
            },
            "Approved assay": {
                "Approved assay": "Yes"
            }
        },
        {
            "Assay Method": "In Vitro Ubiquitination Assay",
            "Material used": {
                "Material Source": "Recombinant Protein",
                "Material Name": "Purified IKKg and parkin",
                "Description": "Affinity-purified FLAG-tagged IKKg and non-phosphorylated or PINK1-phosphorylated parkin were used for in vitro ubiquitination assays."
            },
            "Readout type": "Qualitative",
            "Readout description": [
                {
                    "Variant": "NM_032409.3:c.926G>A",
                    "Conclusion": "N.D.",
                    "Molecular Effect": "N.D.",
                    "Result Description": "Not specifically tested in this assay."
                },
                {
                    "Variant": "NM_032409.3:c.1040T>C",
                    "Conclusion": "N.D.",
                    "Molecular Effect": "N.D.",
                    "Result Description": "Not specifically tested in this assay."
                },
                {
                    "Variant": "NM_004562.3:c.720A>C",
                    "Conclusion": "N.D.",
                    "Molecular Effect": "N.D.",
                    "Result Description": "Not specifically tested in this assay."
                },
                {
                    "Variant": "NM_004562.3:c.933C>T",
                    "Conclusion": "N.D.",
                    "Molecular Effect": "N.D.",
                    "Result Description": "Not specifically tested in this assay."
                },
                {
                    "Variant": "NM_004562.3:c.1244C>A",
                    "Conclusion": "N.D.",
                    "Molecular Effect": "N.D.",
                    "Result Description": "Not specifically tested in this assay."
                }
            ],
            "Biological replicates": {
                "Biological replicates": "N.D.",
                "Description": "Not described in the literature."
            },
            "Technical replicates": {
                "Technical replicates": "N.D.",
                "Description": "Not described in the literature."
            },
            "Basic positive control": {
                "Basic positive control": "Yes",
                "Description": "PINK1-phosphorylated parkin was used as a positive control for enhanced ubiquitination activity."
            },
            "Basic negative control": {
                "Basic negative control": "Yes",
                "Description": "Non-phosphorylated parkin was used as a negative control."
            },
            "Validation controls P/LP": {
                "Validation controls P/LP": "N.D.",
                "Counts": "0"
            },
            "Validation controls B/LB": {
                "Validation controls B/LB": "N.D.",
                "Counts": "0"
            },
            "Statistical analysis method": {
                "Statistical analysis method": "Not described in the literature for this assay."
            },
            "Threshold for normal readout": {
                "Threshold for normal readout": "Detection of polyubiquitinated IKKg bands on immunoblot.",
                "Source": "Custom"
            },
            "Threshold for abnormal readout": {
                "Threshold for abnormal readout": "Absence or significant reduction of polyubiquitinated IKKg bands on immunoblot.",
                "Source": "Custom"
            },
            "Approved assay": {
                "Approved assay": "Yes"
            }
        },
        {
            "Assay Method": "In Vivo Ubiquitination Assay",
            "Material used": {
                "Material Source": "Cell line",
                "Material Name": "SH-SY5Y",
                "Description": "SH-SY5Y cells were transfected with plasmids to assess in vivo ubiquitination of IKKg by parkin."
            },
            "Readout type": "Quantitative",
            "Readout description": [
                {
                    "Variant": "NM_032409.3:c.926G>A",
                    "Conclusion": "Abnormal",
                    "Molecular Effect": "complete loss-of-function",
                    "Result Description": "PINK1 G309D mutation abolished the ability to promote parkin-mediated IKKg polyubiquitination."
                },
                {
                    "Variant": "NM_032409.3:c.1040T>C",
                    "Conclusion": "Abnormal",
                    "Molecular Effect": "complete loss-of-function",
                    "Result Description": "PINK1 L347P mutation abolished the ability to promote parkin-mediated IKKg polyubiquitination."
                },
                {
                    "Variant": "NM_004562.3:c.720A>C",
                    "Conclusion": "N.D.",
                    "Molecular Effect": "N.D.",
                    "Result Description": "Not specifically tested in this assay."
                },
                {
                    "Variant": "NM_004562.3:c.933C>T",
                    "Conclusion": "N.D.",
                    "Molecular Effect": "N.D.",
                    "Result Description": "Not specifically tested in this assay."
                },
                {
                    "Variant": "NM_004562.3:c.1244C>A",
                    "Conclusion": "N.D.",
                    "Molecular Effect": "N.D.",
                    "Result Description": "Not specifically tested in this assay."
                }
            ],
            "Biological replicates": {
                "Biological replicates": "Yes",
                "Description": "Experiments were replicated three times with similar results."
            },
            "Technical replicates": {
                "Technical replicates": "N.D.",
                "Description": "Not described in the literature."
            },
            "Basic positive control": {
                "Basic positive control": "Yes",
                "Description": "Wild-type PINK1 co-expression was used as a positive control for enhanced ubiquitination."
            },
            "Basic negative control": {
                "Basic negative control": "Yes",
                "Description": "Kinase-dead PINK1 KDD mutation and pathogenic mutations were used as negative controls."
            },
            "Validation controls P/LP": {
                "Validation controls P/LP": "N.D.",
                "Counts": "0"
            },
            "Validation controls B/LB": {
                "Validation controls B/LB": "N.D.",
                "Counts": "0"
            },
            "Statistical analysis method": {
                "Statistical analysis method": "Not described in the literature for this assay."
            },
            "Threshold for normal readout": {
                "Threshold for normal readout": "Significant increase in polyubiquitinated IKKg signal compared to control.",
                "Source": "Custom"
            },
            "Threshold for abnormal readout": {
                "Threshold for abnormal readout": "No significant increase in polyubiquitinated IKKg signal compared to control.",
                "Source": "Custom"
            },
            "Approved assay": {
                "Approved assay": "Yes"
            }
        },
        {
            "Assay Method": "NF-kB Reporter Assay",
            "Material used": {
                "Material Source": "Cell line",
                "Material Name": "SH-SY5Y",
                "Description": "SH-SY5Y cells were transfected with NF-kB-Luc reporter plasmid and other constructs to assess NF-kB activation."
            },
            "Readout type": "Quantitative",
            "Readout description": [
                {
                    "Variant": "NM_032409.3:c.926G>A",
                    "Conclusion": "Abnormal",
                    "Molecular Effect": "complete loss-of-function",
                    "Result Description": "PINK1 G309D mutation abrogated the ability to enhance parkin-stimulated NF-kB activation."
                },
                {
                    "Variant": "NM_032409.3:c.1040T>C",
                    "Conclusion": "Abnormal",
                    "Molecular Effect": "complete loss-of-function",
                    "Result Description": "PINK1 L347P mutation abrogated the ability to enhance parkin-stimulated NF-kB activation."
                },
                {
                    "Variant": "NM_004562.3:c.720A>C",
                    "Conclusion": "Abnormal",
                    "Molecular Effect": "complete loss-of-function",
                    "Result Description": "Parkin T240R mutation abolished the ability to rescue NF-kB activation in PINK1-depleted cells."
                },
                {
                    "Variant": "NM_004562.3:c.933C>T",
                    "Conclusion": "Abnormal",
                    "Molecular Effect": "complete loss-of-function",
                    "Result Description": "Parkin Q311X mutation abolished the ability to rescue NF-kB activation in PINK1-depleted cells."
                },
                {
                    "Variant": "NM_004562.3:c.1244C>A",
                    "Conclusion": "Abnormal",
                    "Molecular Effect": "complete loss-of-function",
                    "Result Description": "Parkin T415N mutation abolished the ability to rescue NF-kB activation in PINK1-depleted cells."
                }
            ],
            "Biological replicates": {
                "Biological replicates": "Yes",
                "Description": "Data represent mean + SEM from three independent experiments."
            },
            "Technical replicates": {
                "Technical replicates": "N.D.",
                "Description": "Not described in the literature."
            },
            "Basic positive control": {
                "Basic positive control": "Yes",
                "Description": "Wild-type parkin and PINK1 were used as positive controls for NF-kB activation."
            },
            "Basic negative control": {
                "Basic negative control": "Yes",
                "Description": "EGFP control and kinase-dead PINK1 KDD mutation were used as negative controls."
            },
            "Validation controls P/LP": {
                "Validation controls P/LP": "N.D.",
                "Counts": "0"
            },
            "Validation controls B/LB": {
                "Validation controls B/LB": "N.D.",
                "Counts": "0"
            },
            "Statistical analysis method": {
                "Statistical analysis method": "ANOVA was used for statistical analysis with a P-value of less than 0.05 considered significant."
            },
            "Threshold for normal readout": {
                "Threshold for normal readout": "Significant increase in NF-kB luciferase activity compared to EGFP control.",
                "Source": "Literature"
            },
            "Threshold for abnormal readout": {
                "Threshold for abnormal readout": "No significant increase in NF-kB luciferase activity compared to EGFP control.",
                "Source": "Literature"
            },
            "Approved assay": {
                "Approved assay": "Yes"
            }
        },
        {
            "Assay Method": "Cell Viability and Cytochrome c Release Assay",
            "Material used": {
                "Material Source": "Cell line",
                "Material Name": "SH-SY5Y",
                "Description": "SH-SY5Y cells were used to assess cell viability and cytochrome c release in response to rotenone treatment."
            },
            "Readout type": "Quantitative",
            "Readout description": [
                {
                    "Variant": "NM_032409.3:c.926G>A",
                    "Conclusion": "N.D.",
                    "Molecular Effect": "N.D.",
                    "Result Description": "Not specifically tested in this assay."
                },
                {
                    "Variant": "NM_032409.3:c.1040T>C",
                    "Conclusion": "N.D.",
                    "Molecular Effect": "N.D.",
                    "Result Description": "Not specifically tested in this assay."
                },
                {
                    "Variant": "NM_004562.3:c.720A>C",
                    "Conclusion": "Abnormal",
                    "Molecular Effect": "complete loss-of-function",
                    "Result Description": "Parkin T240R mutation abolished the ability to rescue cell survival in PINK1-depleted cells."
                },
                {
                    "Variant": "NM_004562.3:c.933C>T",
                    "Conclusion": "Abnormal",
                    "Molecular Effect": "complete loss-of-function",
                    "Result Description": "Parkin Q311X mutation abolished the ability to rescue cell survival in PINK1-depleted cells."
                },
                {
                    "Variant": "NM_004562.3:c.1244C>A",
                    "Conclusion": "Abnormal",
                    "Molecular Effect": "complete loss-of-function",
                    "Result Description": "Parkin T415N mutation abolished the ability to rescue cell survival in PINK1-depleted cells."
                }
            ],
            "Biological replicates": {
                "Biological replicates": "Yes",
                "Description": "Data represent mean + SEM from three independent experiments."
            },
            "Technical replicates": {
                "Technical replicates": "N.D.",
                "Description": "Not described in the literature."
            },
            "Basic positive control": {
                "Basic positive control": "Yes",
                "Description": "Wild-type parkin overexpression was used as a positive control for cell survival."
            },
            "Basic negative control": {
                "Basic negative control": "Yes",
                "Description": "PINK1 siRNA transfection was used as a negative control for cell survival."
            },
            "Validation controls P/LP": {
                "Validation controls P/LP": "N.D.",
                "Counts": "0"
            },
            "Validation controls B/LB": {
                "Validation controls B/LB": "N.D.",
                "Counts": "0"
            },
            "Statistical analysis method": {
                "Statistical analysis method": "ANOVA was used for statistical analysis with a P-value of less than 0.05 considered significant."
            },
            "Threshold for normal readout": {
                "Threshold for normal readout": "Significant increase in cell viability or reduction in cytochrome c release compared to PINK1-depleted cells.",
                "Source": "Literature"
            },
            "Threshold for abnormal readout": {
                "Threshold for abnormal readout": "No significant increase in cell viability or reduction in cytochrome c release compared to PINK1-depleted cells.",
                "Source": "Literature"
            },
            "Approved assay": {
                "Approved assay": "Yes"
            }
        }
    ]
}